Bottom line
PAWZ vs ANWPX: the short answer
PAWZ (ProShares Pet Care ETF) and ANWPX (New Perspective Fund) are both etfs.
But ANWPX is far broader, holding 295 positions to 38 for PAWZ, so beyond the top names it adds exposure PAWZ doesn't have.
PAWZ is cheaper at 0.5% vs 0.71% — a difference of $21 a year per $10,000 invested.
Over five years, ANWPX returned +9.8% a year vs −4.7% for PAWZ (reporting dates differ).
ANWPX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
PAWZ vs ANWPX side by side
| PAWZ | ANWPX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | ProShares | American Funds (Capital Group) |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.5% | 0.71% |
| Annual cost per $10k | $50 | $71 |
| 10-yr cost on $10k (prospectus) | $628 | $1,407 |
| Max front load | None | 5.75% |
| 12b-1 fee | — | 0.24% |
| 1-yr return | +0.9% | +10.1% |
| 5-yr return (annualized) | −4.7% | +9.8% |
| 10-yr return (annualized) | — | +10.5% |
| Best quarter | +26.2% | +23.9% |
| Worst quarter | −20.7% | −19.0% |
| Net assets (fund) | $32.5M | $170.4B |
| Number of holdings | 38 | 295 |
| Portfolio turnover | 41% | 23% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
PAWZ and ANWPX share none of their top holdings.
PAWZ top 10
- IDEXX Laboratories, Inc. — 10.15%
- Chewy, Inc. — 9.90%
- Freshpet, Inc. — 9.81%
- Zoetis, Inc. — 9.46%
- Virbac SACA — 7.37%
- CVS Group plc — 4.99%
- Merck & Co., Inc. — 4.84%
- Pets at Home Group plc — 4.71%
- Nestle SA — 4.64%
- Oil-Dri Corp. of America — 4.50%
ANWPX top 10
- Taiwan Semiconductor Manufacturing Co Ltd — 4.88%
- Meta Platforms Inc — 3.26%
- Nvidia Corp — 3.14%
- Broadcom Inc — 3.13%
- Tesla Inc — 2.79%
- Capital Group Central Cash Fund — 2.28%
- Microsoft Corp — 2.05%
- Asml Holding Nv — 1.94%
- Sk Hynix Inc — 1.91%
- Micron Technology Inc — 1.74%
FAQ
What is the difference between PAWZ and ANWPX?
Which is cheaper, PAWZ or ANWPX?
Should I own both PAWZ and ANWPX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.